The Department of Translational Hematology and Oncology Research (THOR) conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patient care.
Using Artificial Intelligence to Deliver Personalized Radiation Therapy
Advancing Therapy by Measuring the ‘Games’ Cancer Cells Play
Five Researchers Win Annual Fund Grants
Research Team Identifies Mutation that Promotes Liver Cancer